Do Apixaban Plasma Levels Relate to Bleeding? The Clinical Outcomes and Predictive Factors for Bleeding in Patients with Non-Valvular Atrial Fibrillation
Apixaban can significantly prevent stroke events in patients with non-valvular atrial fibrillation (NVAF), as can be observed from the large, randomized, controlled trial conducted in the present study. However, the real-world evidence of bleeding events related to the apixaban plasma levels in Asia...
Main Authors: | Sutee Limcharoen, Manat Pongchaidecha, Piyarat Pimsi, Sarawuth Limprasert, Juthathip Suphanklang, Weerayuth Saelim, Wichai Santimaleeworagun, Pornwalai Boonmuang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/8/2001 |
Similar Items
-
Does amiodarone impact on apixaban levels? The effect of amiodarone on apixaban level among Thai patients with non-valvular Atrial Fibrillation.
by: Sutee Limcharoen, et al.
Published: (2024-01-01) -
Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation
by: Marco Bellone, et al.
Published: (2018-02-01) -
Thromboembolism and Major Bleeding in Patients with Atrial Fibrillation and EHRA Type 2 Valvular Heart Disease: The Jordan Atrial Fibrillation (JoFib) Study
by: Al-Najar M, et al.
Published: (2023-03-01) -
Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation
by: Steven Deitelzweig, et al.
Published: (2024-02-01) -
The impact of ABCB1, CYP3A4/5 and ABCG2 gene polymorphisms on rivaroxaban trough concentrations and bleeding events in patients with non-valvular atrial fibrillation
by: Tingting Wu, et al.
Published: (2023-07-01)